Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study.

Summary: Surgery is currently the main treatment for liver metastases caused by colorectal cancer, but unfortunately, the cancer often returns. Doctors are constantly searching for better ways to predict which patients are at highest risk of recurrence so they can provide more targeted care. A recent study explored the use of "liquid biopsies"—simple blood tests that detect tiny fragments of tumor DNA (ctDNA)—in 51 patients undergoing liver surgery. The researchers tested patients before and after the operation. They found that patients who still had detectable tumor DNA in their blood after surgery were nearly three times more likely to experience a cancer recurrence compared to those whose blood cleared. This suggests that checking for persistent tumor DNA after surgery is a powerful tool for predicting long-term outcomes.